School of Medicine
Showing 6,821-6,840 of 12,916 Results
-
Angela K. Lumba-Brown
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsCurrent Research and Scholarly InterestsCurrent research includes evidence-based guidelines for the management and treatment of traumatic brain injury, research establishing an evidence and targeting treatments for the subtypes of concussion, research identifying the best outcomes in pre-hospital care of patients with traumatic brain injury, research on brain performance via sensorimotor and sensory-cognitive synchronization, and research on dynamic visual synchronization as a biomarker for attentional impairments.
-
Gabriela Luna-Victoria
Casual - Non-Exempt, Obstetrics Anesthesiology
Current Role at StanfordAdministrative Associate in the Department of Pediatrics, Division of Neonatal and Developmental Medicine at Stanford School of Medicine
Administrative support to: Jochen Profit, Gary Darmstadt, Suzan Carmichael, Anca Pasca -
Dennis Lund
Elizabeth Wood Dunlevie Professor, Emeritus
BioDr. Lund was born in Duluth, MN and attended Harvard College and Harvard Medical School. He received his general surgical training at the MGH in Boston, and his pediatric surgical training at Boston Children's Hospital. His initial career was spent as a trauma, transplant and general pediatric surgeon at Boston Children's. In 1999, he became Surgeon-in-Chief of the University of Wisconsin Children's Hospital in in Madison, and in 2001 became Chair of General Surgery at the University of Wisconsin-Madison. In 2011, he became Executive Vice President of the Phoenix Children's Medical Group and Surgeon-in-Chief at Phoenix Children's Hospital. Dr. Lund joined the Stanford faculty in Pediatric Surgery and as Associate Dean of the Faculty in Pediatrics and Obstetrics (Clinical Affairs) as well as Chief Medical Officer at Lucile Packard Children's Hospital in March, 2015. In March of 2018 and through January of 2019, Dr. Lund served as interim President and CEO of Lucile Packard Children's Hospital.
-
Emma Lundberg
Associate Professor of Bioengineering and of Pathology
BioDr. Emma Lundberg is an Associate Professor of Bioengineering and Pathology at Stanford University and serves at the Director of the Cell Atlas of the Human Protein Atlas initiative in Sweden, where she is also Professor at KTH Royal Institute of Technology. At the intersection of bioimaging, proteomics, and artificial intelligence, her research aims to define the spatiotemporal organization of the human proteome at both cellular and subcellular level. Dr. Lundberg aims to develop integrated models of human cells to elucidate how variations in protein localization patterns influence cellular function, ultimately enabling the simulation of cell behavior and a systems-level understanding of how biological information is spatially encoded. The Lundberg Lab is responsible for creating the Subcellular Atlas of the Human Protein Atlas database (https://www.proteinatlas.org/). Dr. Lundberg is dedicated to building virtual cell models to simulate cell behavior, and is passionate about engaging the public in her work through citizen science games and computational challenges.
Dr. Lundberg holds a Master’s degree in Bioengineering and a PhD in Biotechnology from KTH Royal Institute of Technology in Sweden. She has served as Secretary General of the Human Proteome Organization, and is actively involved in advisory roles for numerous open-access databases and cell mapping efforts such as the CZI AI Virtual Cell, Human Cell Atlas consortium, UniProt db, Reactome db, Human Proteome Project and various pharma and biotech companies. As a token of her leadership skills and advocate for open science, she was twice recognized as top 10 under 40 for future leaders in biopharma and omics. -
Francesca Alejandro
Affiliate, Orthopaedic Surgery
BioFrancesca Alejandro, NP was born and raised in the San Francisco Bay Area and has resided here for most of her life. She attended San Jose State University, where she obtained her Bachelors in Public Health and minor in Child Development. Seeking to further her education, she attended Western University of Health Sciences and obtained her Masters in Ambulatory Nursing and Family Nurse Practitioner degrees.
Francesca Alejandro, NP started working at Stanford in 2008, at the time as an Operating Room assistant, and was fortunate to come back once she completed her training as a Nurse Practitioner. Francesca enjoys collegiality of the Academic setting and has a passion for Medicine, specifically Orthopedics. She enjoys spending time with her patients and educating them on how to manage their conditions and improve their health. In her spare time she enjoys traveling, medical missions, cooking, spending time with family, and watching football. -
Matthew Lungren
Adjunct Professor, Biomedical Data Science
BioDr. Matthew Lungren is a physician-scientist and AI leader whose work has helped shape modern multimodal healthcare AI from early research through large-scale deployment. He joined Stanford University in 2014 as clinical research faculty, where he led a fully dedicated pediatric interventional radiology clinical service and established an NIH- and industry-supported clinical AI research program that helped catalyze what became the Stanford Center for AI in Medicine & Imaging. He remains an Adjunct Professor of Biomedical Data Science at Stanford and also holds a part-time clinical appointment at UCSF.
Dr. Lungren has authored more than 200 peer-reviewed publications with more than 35,000 citations, and he has taught more than 100,000 learners through AI-in-healthcare courses across platforms including Coursera and LinkedIn Learning. His broader contributions include advancing multimodal imaging-plus-EHR approaches, open-sourcing AI-ready medical imaging datasets and models, and serving in national leadership roles across the radiology AI community. After a sabbatical in 2021, he transitioned from academia to industry and joined Microsoft, where he served in senior leadership roles including Chief Scientific Officer for Microsoft Health & Life Sciences. At Microsoft, he founded and led cross-company teams that shipped multimodal healthcare foundation models and agentic, auditable generative AI workflows into production, including healthcare agent orchestration capabilities and major EHR partnerships, and led the health and life sciences partnerships with OpenAI.
Dr. Lungren is also a top rated instructor leading AI in Healthcare courses designed especially for learners with non-technical backgrounds:
Stanford/Coursera: https://www.coursera.org/learn/fundamental-machine-learning-healthcare
LinkedIn Learning: https://www.linkedin.com/learning/an-introduction-to-how-generative-ai-will-transform-healthcare -
Mitchell R. Lunn
Associate Professor of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsLGBTQIA+ health
-
Liqun Luo
Ann and Bill Swindells Professor and Professor, by courtesy, of Neurobiology
Current Research and Scholarly InterestsWe study how neurons are organized into specialized circuits to perform specific functions and how these circuits are assembled during development. We have developed molecular-genetic and viral tools, and are combining them with transcriptomic, proteomic, physiological, and behavioral approaches to study these problems. Topics include: 1) assembly of the fly olfactory circuit; 2) assembly of neural circuits in the mouse brain; 3) organization and function of neural circuits; 4) Tool development.
-
Ruben Y. Luo
Assistant Professor of Pathology
Current Research and Scholarly InterestsApply top-down mass spectrometry and label-free immunoassay to the study and utilization of biomarker proteoforms in clinical diagnosis.
-
Xiangde Luo
Postdoctoral Scholar, Radiation Physics
BioXiangde Luo is a postdoctoral researcher in Professor Ruijiang Li’s lab at Stanford Medicine, where he specializes in computational pathology. His work centers on developing AI‑driven methods for imaging biomarker discovery and precision oncology. Previously, he has developed some deep learning models to enable annotation‑efficient learning and advance biomedical image analysis. For a comprehensive overview of my research, please visit my Google Scholar profile: https://scholar.google.com/citations?hl=en&user=dD4HLS4AAAAJ. If you’d like to learn more or discuss potential collaborations, please don’t hesitate to get in touch.
-
XIAOHUA LUO
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
Visiting Scholar, Institute for Immunity, Transplantation, and Infection OperationsBioAcademic Appointments
- Visiting Scholar, Stanford University School of Medicine (Holden Maecker Lab)
- Chief Physician / Associate Professor / Associate Research Scientist, The First Affiliated Hospital of Chongqing Medical University
Professional Education
- Visiting Scholar, Karolinska Institutet (Per Ljungman & Markus Maeurer Lab) (2016)
- Ph. D., Peking University Health Science Centre (2009)
- B.Med., Tongji Medical College, Huazhong University of Science and Technology (2001)
Selected Publications:
- Luo XH*, Zhu Y, Duan XQ, Peng W, Pei CX, Yang L, Li Q, Zhao M, Wang L. Histone HIST1 genes and tumor-infiltrating lymphocytes in a child with γδ T cell acute lymphoblastic leukemia by single-cell sequencing. Journal of Leukocyte Biology. 2025 Apr;117(4):qiaf022.
- Shui LP, Zhu Y, Duan XQ, Chen YT, Yang L, Tang XQ, Zhang HB, Xiao Q, Wang L, Liu L, Luo XH*. HBsAg (‐)/HBsAb (‐)/HBeAg (‐)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B ‐ cell lymphoma receiving rituximab based immunochemotherapy. Journal of Medical Virology. 2023 Feb 3.
- Luo XH*, Poiret T, Liu Z, Meng Q, Nagchowdhury A, Ljungman P. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse. Frontiers in Immunology. 2022;13.
- Luo XH*, Zhu Y, Chen YT, Shui LP, Liu L. CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update. Frontiers in immunology. 2021;12.
- Luo XH*, Meng Q, Liu Z, Paraschoudi G. Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21. Clinical Immunology. 2020 Aug 1;217:108456.
- Li S, Huang J, Zhang YL, Zhu Y, An YF, Du J, Zhang ZL, Xia Y, Liu L, Wang L, Luo XH*. Wiskott- Aldrich syndrome protein may be critical for CD8+ T cell function following MCMV infection. Cellular immunology. 2019 Apr 1;338:43-50.
- Luo XH, Meng Q, Rao M, Liu Z, Paraschoudi G, Dodoo E, Maeurer M. The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer. Immunology. 2018 Nov;155(3):294-308.
- Zhenjiang L, Rao M, Luo X, Valentini D, von Landenberg A, Meng Q, Sinclair G, Hoffmann N, Karbach J, Altmannsberger HM, Jäger E. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme. EBioMedicine. 2018 Jul 1;33:49-56.
- Liu Zhenjiang, Martin Rao, Xiaohua Luo, Elisabeth Sandberg, Jiri Bartek Jr, Esther Schoutrop, Anna von Landenberg, Qingda Meng, Davide Valentini, Thomas Poiret, Georges Sinclair, Inti- Harvey Peredo, Ernest Dodoo, and Markus Maeurer*. Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis. EBioMedicine. 2017 Sep; 23: 20–24.
- Liu Z, Poiret T, Persson O, Meng Q, Rane L, Bartek J, Karbach J, Altmannsberger HM, Illies C, Luo X, Harvey-Peredo I. NY-ESO-1-and survivin-specific T-cell responses in the peripheral blood from patients with glioma. Cancer Immunology, Immunotherapy. 2018 Feb 1;67(2):237- 46.
- Liu Z, Meng Q, Bartek Jr J, Poiret T, Persson O, Rane L, Rangelova E, Illies C, Peredo IH, Luo X, Rao MV. Tumor-infiltrating lymphocytes (TILs) from patients with glioma. Oncoimmunology. 2017 Feb 1;6(2):e1252894.
- XH Luo, XJ Huang*, KY Liu, LP Xu, DH Liu. Protective immunity transferred by infusion of CMV- specific CD8+ T cells within donor grafts: its associations with CMV reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16(7):994-1004
- XH Luo, YJ Chang, LP Xu, DH Liu, KY Liu, XJ Huang*. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical haematopoietic SCT. Bone Marrow Transplant 2009; 43(1):29-36.
